Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas cohort

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 1, 1998, Pages 35-42

  Siest, Gérard ^a,b   Visvikis, Sophie ^a,b   Herbeth, Bernard ^a,b   Gueguen, René ^a   Vincent Viry, Monique ^a,b   Sass, Catherine ^a,b   Beaud, Brigitte ^a   Lecomte, Edith ^a   Steinmetz, Josiane ^a   Locuty, Jean ^a   Chevrier, Philippe ^a  

^a Centre de Medecine Preventive   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Cardiovascular disease; Familial study; Gene environment interactions; Longitudinal study

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; FEMALE; FEMORAL ARTERY; FOOD INTAKE; GENETIC POLYMORPHISM; HEART WEIGHT; HEREDITY; HUMAN; LIPID METABOLISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; TOBACCO;

ADULT; AGED; CARDIOVASCULAR DISEASES; CLINICAL LABORATORY INFORMATION SYSTEMS; COHORT STUDIES; CRYOPRESERVATION; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT;

NICOTIANA TABACUM;

EID: 0031979092     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.007     Document Type: Article

References (31)

1. Lusis AJ, Rotter JI, Sparkes RS. Molecular genetics of coronary artery disease. Candidate genes and processes in atherosclerosis. In: Sparkes RS, editor. Monographs in human genetics, Bâle: Karger, 1992.
2. Esterbauer H, Schmidt R, Hayn M. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv Pharmacol 1997; 38: 425-56.
3. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123:860-72.
4. Dammerman M, Breslow JL. Genetic basis of lipoprotein disorders. Circulation 1995; 91: 505-12.
5. Hegele RA. Gene-environment interactions in atherosclerosis. Mol Cell Biochem 1992; 113: 177-86.
6. Ottman R. Gene-environment interaction and public health. Am J Hum Genet 1995; 56: 821-23.
7. Siest G, Visvikis S, Bayad J, Zaiou M, Regis A, Jaid M, et al. The role of genetics in defining reference values and health status. Meth Inform Med 1993; 32: 255-9.
8. Perusse L, Despres JP, Tremblay A, Leblanc C, Talbot J, Allard C, et al. Genetic and environmental determinants of serum lipids and lipoproteins in French Canadian families. Arteriosclerosis 1989; 9: 308-18.
9. Williamson R, Kessling AM. The problem of polygenic disease. Ciba Found Symp 1990; 149: 63-80.
10. Siest G, Henny J, Galteau MM, Schiele F, Steinmetz J, Visvikis S. Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers. Clin Biochem 1995; 28: 31-8.
11. Tiret L, Steinmetz J, Herbeth B, Visvikis S, Rakotovao R, Ducimetiere P, et al. Familial resemblance of plasma apolipoprotein B: the Nancy study. Genet Epidemiol 1990; 7: 187-97.
12. Tiret L, Rigab B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis, that variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
13. Zaiou M, Visvikis S, Gueguen R, Steinmetz J, Parra HJ, Fruchart JC, et al. Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolism. Genet Epidemiol 1994; 11: 101-14.
14. Zaiou M, Visvikis S, Gueguen R, Parra HJ, Fruchart JC, Siest G. DNA polymorphism of human polipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in French population. Clin Genet 1994; 46: 248-54.
15. Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 1992; 92: 219-27.
16. Hallman DM, Visvikis S, Steinmetz J, Boerwinkle J. The effect of variation in the apolipoprotein B gene on plasma lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis. Ann Hum Genet 1994; 58:35-64.
17. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash S, Sing CF. The use of measured genotype information in the analysis of quantiative phenotype in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, beta-lipoprotein and triglycerides in a sample of unrelated individuals. Am J med Genet 1987; 27: 567-82.
18. Schulte PA, Perera FP. Molecular epidemiology: principles and practices. San Diego: Academic Press, 1993.
19. Sobell JL, Heston LL, Sommer S. Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics 1992; 12: 1-6.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
21. Vauthier JM, Lluch A, Lecomte A, Artur Y, Herbeth B. Family resemblance in energy and macronutrients intakes/the Stanislas Family Study. Int J Epidemiol 1996; 25: 1030-7.
22. Lecomte E, Herbeth B, Nicaud V, Rakotovao R, Artur Y, Tiret L. Segregation analysis of fat mass, fat-free mass and percent body fat: the Stanislas Family Study. Genet Epidemiol 1997; 14: 51-62.
23. Georges JL, Regis-Bailly A, Salah D, Rakotovao R, Siest G, Visvikis S, et al. Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol 1996; 13: 179-92.
24. Bohnet K, Regis-Bailly A, Vincent-Viry M, Gueguen R, Siest G, Visvikis S. Apolipoprotein E genotype ε4/ε2 in the Stanislas Cohort Study. Dominance of the ε2 allele? Ann Hum Genet 1996; 60: 509-16.
25. Salah D, Bohnet K, Gueguen R, Siest G, Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas Cohort. J Lipid Res 1997; 38: 904-12.
26. Zureik M, Bonithon-Kopp C, Lecomte E, Siest G, Ducimetiere P. Weights at birth and in early infancy, systolic blood pressure and left ventricular structure in subjects aged 8-24 years. Hypertension 1996; 27: 339-45.
27. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7.
28. Khoury MJ, Wagener DK. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995; 56: 835-44.
29. Noma A, Hata Y, Goto Y. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age-sex-related differences. Clin Chim Acta 1991; 199: 147-58.
30. Ronca-Testoni S. Direct spectrophotometric assay for angiotensin-converting enzyme in serum. Clin Chem 1983; 29: 1093-6.
31. Eckerson HW, Romson J, Wyte CM, La Du BN. The human serum paraoxonase arylesterase polymorphism. Identification of phenotype by their response to salts. Am J Hum Genet 1983; 35: 214-27.